This chemical is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active compounds. It is often incorporated into the development of small molecule inhibitors targeting specific enzymes or receptors, particularly in the context of drug discovery for various diseases. Its trifluoromethyl group enhances the compound's metabolic stability and binding affinity, making it valuable in the design of pharmaceuticals. Additionally, it may be used in research to study structure-activity relationships (SAR) to optimize the efficacy and selectivity of potential drug candidates.